BNP Paribas Financial Markets’s Accretive Health AH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-762
Closed -$6.98K 4214
2013
Q4
$6.98K Sell
762
-14,878
-95% -$128K ﹤0.01% 2882
2013
Q3
$143K Sell
15,640
-4,628
-23% -$46K ﹤0.01% 2342
2013
Q2
$219K Buy
+20,268
New +$213K ﹤0.01% 2251

Other funds holding AH

BNP Paribas Financial Markets's AH Position: Q1 2014 in Review

BNP Paribas Financial Markets sold out of Accretive Health (AH) in Q1 2014, closing a stake of 762 shares — an estimated $6.98K sold.

BNP Paribas Financial Markets first reported a position in AH in Q2 2013 and held it in 3 quarters. The position peaked at $219K in Q2 2013. 66 funds tracked by Wall St. Rank hold AH as of Q1 2014.

  • BNP Paribas Financial Markets reported no remaining Accretive Health position as of Q1 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 762 Accretive Health shares in Q1 2014, an estimated $6.98K.
  • BNP Paribas Financial Markets first reported a position in Accretive Health in Q2 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Accretive Health position peaked at $219K in Q2 2013.
  • 66 funds tracked by Wall St. Rank held Accretive Health as of Q1 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.